The decrease in TNF-α along with an increase in IL-10 in response to probiotic therapy, suggests possible anti-inflammatory and regulatory mechanisms, highlighting the potential of probiotics to modulate systemic inflammation and reduce disease activity in RA. This evidence concerns the gene IL10 and rheumatoid arthritis.